Feed‐Forward Deep Neural Networks Predict Substrate‐Specific Effects of Transporter Variants to Explain Drug Response Variability

) with experimental uptake than commonly used substrate-agnostic predictors. Application of SSEP on UK Biobank data revealed that OCT1 (SLC22A1) variant burden weighted by metformin-specific SSEP scores was significantly associated with maintenance dose (β = 30 mg/day per unit increase in predicted functional burden; p = 0.033), whereas substrate-agnostic weights showed no association (p = 0.78). Together, these results show that SSEP enables quantitative, drug-specific prediction of transporter variant effects, thereby improving the identification of clinically relevant transporter variants in population-scale data.

Authors

Institutions

Publication Details

Journal
Clinical and Translational Science
Published
2026-05-01
DOI
https://doi.org/10.1111/cts.70592
Primary Topic
Drug Transport and Resistance Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Feed‐Forward Deep Neural Networks Predict Substrate‐Specific Effects of Transporter Variants to Explain Drug Response Variability

Anne T. Nies, Yoomi Park, Yitian Zhou, Volker M. Lauschke et al.
Clinical and Translational Science
Drug Transport and Resistance Mechanisms
article

Feed‐Forward Deep Neural Networks Predict Substrate‐Specific Effects of Transporter Variants to Explain Drug Response Variability

Anne T. Nies, Yoomi Park, Yitian Zhou, Volker M. Lauschke, Ming Xiao
article en

Abstract

) with experimental uptake than commonly used substrate-agnostic predictors. Application of SSEP on UK Biobank data revealed that OCT1 (SLC22A1) variant burden weighted by metformin-specific SSEP scores was significantly associated with maintenance dose (β = 30 mg/day per unit increase in predicted functional burden; p = 0.033), whereas substrate-agnostic weights showed no association (p = 0.78). Together, these results show that SSEP enables quantitative, drug-specific prediction of transporter variant effects, thereby improving the identification of clinically relevant transporter variants in population-scale data.

Clinical and Translational ScienceVol. 19(5)
Karolinska University Hospital (SE), Seoul National University (KR), Central South University (CN), Karolinska Institutet (SE), Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (DE), Research Institute for Work, Technology and Culture (DE), Second Xiangya Hospital of Central South University (CN), University of Tübingen (DE), KTH Royal Institute of Technology (SE)
Deutsche Forschungsgemeinschaft, National Research Foundation of Korea, Vetenskapsrådet
Good health and well-being
Openalex Percentile: Top 7%
Drug Transport and Resistance Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Feed‐Forward Deep Neural Networks Predict Substrate‐Specific Effects of Transporter Variants to Explain Drug Response Variability — Anne T. Nies, Yoomi Park, et al. · Clinical and Translational Science (2026) | TGRS Research Map | TGRS